Who invested in Aristea Therapeutics?
Aristea Therapeutics's investors include Fidelity, Novo Holdings and Novo Holdings A/S.
United States · Series B startup
Funding summaryUpdated 26 Oct 2026
$78Mraised across 2 rounds since 2018, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
From the SEC filings it signed: 1 on the team.
On the board, as filediCiara KennedyKenneth HarrisonLoretta TseTiba Aynechi
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Aristea Therapeutics's investors include Fidelity, Novo Holdings and Novo Holdings A/S.
Aristea Therapeutics has raised $78M across 2 rounds since 2018.
Aristea Therapeutics's most recent round was a Series B of $63M in Jul 2021.
Its most recent round, $63M in Jul 2021, is also its largest on record.
Aristea Therapeutics's first round on record, in Dec 2018, was backed by Novo Holdings A/S.
Aristea Therapeutics's latest named round is a Series B, in Jul 2021.
Aristea Therapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.